Journal of the Korean Association of Oral and Maxillofacial Surgeons

The Korean Association of Oral and Maxillofacial Surgeons (대한구강악안면외과학회)
권호 표지
DOI QR코드

DOI QR Code

Count of platelet and mean platelet volume score: serologic prognostic factor in patients with oral squamous cell carcinoma

  • Park, Jae Woo (Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook University) ;
  • Kim, Chul-Hwan (Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook University) ;
  • Ha, Yong Chan (Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook University) ;
  • Kim, Moon Young (Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook University) ;
  • Park, Sung Min (Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook University)
  • Received : 2017.03.02
  • Accepted : 2017.05.26
  • Published : 2017.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: TNM staging, especially for lymph node metastasis, is the scoring system most widely used among prognostic factors for cancer survival. Several biomarkers have been studied as serologic markers, but their specificity is low and clinical applications are difficult. This study aimed to establish a scoring system for patients with oral squamous cell carcinoma (OSCC) using platelet (PLT) and mean platelet volume (MPV) levels measured postoperatively and to evaluate their significance as prognostic factors. Materials and Methods: We studied 40 patients admitted to the Department of Oral and Maxillofacial Surgery of Dankook University Hospital who were diagnosed with primary OSCC histopathologically between May 2006 and May 2012. Clinical pathological information obtained from the medical records of each patient included age, sex, height, weight, tumor location, degree of differentiation, tumor diameter, lymph node metastasis, TNM stage, and other test values including white blood cell, MPV, PLT, C-reactive protein (CRP), and albumin obtained through a test conducted within 7 days before surgery. Count of platelet (COP)-MPV Score: Patients with both PLT and MPV values below the cut-off values were defined as score 0 (group A). Patients with at least one of the two higher than the cut-off value were defined as score 1 (group B). Results: Univariate analyses showed N-metastasis, COP-MPV (A vs B), PLT, platelet-lymphocyte ratio, and CRP were statistically significant prognostic factors. A multivariate Cox proportional hazards model showed N-metastasis (hazard ratio [HR] 6.227, P=0.016) and COP-MPV (A vs B) (HR 18.992, P=0.013) were independent prognostic factors with a significant effect on survival. Conclusion: COP-MPV score is a simple and cost-effective test method and is considered a more effective prognostic factor than other considered factors in predicting the prognosis of OSCC patients.

Keywords

References

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30. https://doi.org/10.3322/caac.21166
  2. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86. https://doi.org/10.1002/ijc.29210
  3. Johnson N. Tobacco use and oral cancer: a global perspective. J Dent Educ 2001;65:328-39.
  4. Reibel J. Tobacco and oral diseases. Update on the evidence, with recommendations. Med Princ Pract 2003;12 Suppl 1:22-32. https://doi.org/10.1159/000069845
  5. Lewin F, Norell SE, Johansson H, Gustavsson P, Wennerberg J, Biorklund A, et al. Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden. Cancer 1998;82:1367-75. https://doi.org/10.1002/(SICI)1097-0142(19980401)82:7<1367::AID-CNCR21>3.0.CO;2-3
  6. Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for squamous cell carcinoma of the oral cavity in young people--a comprehensive literature review. Oral Oncol 2001;37:401-18. https://doi.org/10.1016/S1368-8375(00)00135-4
  7. Singh B, Bhaya M, Zimbler M, Stern J, Roland JT, Rosenfeld RM, et al. Impact of comorbidity on outcome of young patients with head and neck squamous cell carcinoma. Head Neck 1998;20:1-7. https://doi.org/10.1002/(SICI)1097-0347(199801)20:1<1::AID-HED1>3.0.CO;2-8
  8. Schantz SP, Yu GP. Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg 2002;128:268-74. https://doi.org/10.1001/archotol.128.3.268
  9. Lydiatt DD, Robbins KT, Byers RM, Wolf PF. Treatment of stage I and II oral tongue cancer. Head Neck 1993;15:308-12. https://doi.org/10.1002/hed.2880150407
  10. Layland MK, Sessions DG, Lenox J. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Laryngoscope 2005;115:629-39. https://doi.org/10.1097/01.mlg.0000161338.54515.b1
  11. Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med 2001;345:1890-900. https://doi.org/10.1056/NEJMra001375
  12. Woolgar JA, Rogers S, West CR, Errington RD, Brown JS, Vaughan ED. Survival and patterns of recurrence in 200 oral cancer patients treated by radical surgery and neck dissection. Oral Oncol 1999;35:257-65. https://doi.org/10.1016/S1368-8375(98)00113-4
  13. Yotsukura S, Mamitsuka H. Evaluation of serum-based cancer biomarkers: a brief review from a clinical and computational viewpoint. Crit Rev Oncol Hematol 2015;93:103-15. https://doi.org/10.1016/j.critrevonc.2014.10.002
  14. Lip GY, Chin BS, Blann AD. Cancer and the prothrombotic state. Lancet Oncol 2002;3:27-34. https://doi.org/10.1016/S1470-2045(01)00619-2
  15. Nash GF, Turner LF, Scully MF, Kakkar AK. Platelets and cancer. Lancet Oncol 2002;3:425-30. https://doi.org/10.1016/S1470-2045(02)00789-1
  16. Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer 2011;11:123-34. https://doi.org/10.1038/nrc3004
  17. Kamath S, Blann AD, Lip GY. Platelet activation: assessment and quantification. Eur Heart J 2001;22:1561-71. https://doi.org/10.1053/euhj.2000.2515
  18. Kai H, Kitadai Y, Kodama M, Cho S, Kuroda T, Ito M, et al. Involvement of proinflammatory cytokines IL-1beta and IL-6 in progression of human gastric carcinoma. Anticancer Res 2005;25:709-13.
  19. Kurt M, Onal IK, Sayilir AY, Beyazit Y, Oztas E, Kekilli M, et al. The role of mean platelet volume in the diagnosis of hepatocellular carcinoma in patients with chronic liver disease. Hepatogastroenterology 2012;59:1580-2.
  20. Karaman K, Bostanci EB, Aksoy E, Kurt M, Celep B, Ulas M, et al. The predictive value of mean platelet volume in differential diagnosis of non-functional pancreatic neuroendocrine tumors from pancreatic adenocarcinomas. Eur J Intern Med 2011;22:e95-8.
  21. Kilincalp S, Ekiz F, Basar O, Ayte MR, Coban S, Yilmaz B, et al. Mean platelet volume could be possible biomarker in early diagnosis and monitoring of gastric cancer. Platelets 2014;25:592-4. https://doi.org/10.3109/09537104.2013.783689
  22. Connolly GC, Phipps RP, Francis CW. Platelets and cancer-associated thrombosis. Semin Oncol 2014;41:302-10. https://doi.org/10.1053/j.seminoncol.2014.04.009
  23. Stegner D, Dutting S, Nieswandt B. Mechanistic explanation for platelet contribution to cancer metastasis. Thromb Res 2014;133 Suppl 2:S149-57. https://doi.org/10.1016/S0049-3848(14)50025-4
  24. Caine GJ, Lip GY, Stonelake PS, Ryan P, Blann AD. Platelet activation, coagulation and angiogenesis in breast and prostate carcinoma. Thromb Haemost 2004;92:185-90.
  25. Li L, Li P, Yang YQ, Zhang H, Ai P, Wang F, et al. sCD40L, sPselectin and sICAM-1 plasma levels in nasopharyngeal carcinoma. Sichuan Da Xue Xue Bao Yi Xue Ban 2009;40:513-6.
  26. Peterson JE, Zurakowski D, Italiano JE Jr, Michel LV, Connors S, Oenick M, et al. VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients. Angiogenesis 2012;15:265-73. https://doi.org/10.1007/s10456-012-9259-z
  27. Azab B, Torbey E, Singh J, Akerman M, Khoueiry G, McGinn JT, et al. Mean platelet volume/platelet count ratio as a predictor of long-term mortality after non-ST-elevation myocardial infarction. Platelets 2011;22:557-66. https://doi.org/10.3109/09537104.2011.584086
  28. Slavka G, Perkmann T, Haslacher H, Greisenegger S, Marsik C, Wagner OF, et al. Mean platelet volume may represent a predictive parameter for overall vascular mortality and ischemic heart disease. Arterioscler Thromb Vasc Biol 2011;31:1215-8. https://doi.org/10.1161/ATVBAHA.110.221788
  29. Cho SY, Yang JJ, You E, Kim BH, Shim J, Lee HJ, et al. Mean platelet volume/platelet count ratio in hepatocellular carcinoma. Platelets 2013;24:375-7. https://doi.org/10.3109/09537104.2012.701028
  30. Osada J, Rusak M, Kamocki Z, Dabrowska MI, Kedra B. Platelet activation in patients with advanced gastric cancer. Neoplasma 2010;57:145-50. https://doi.org/10.4149/neo_2010_02_145
  31. Mutlu H, Artis TA, Erden A, Akca Z. Alteration in mean platelet volume and platicrit values in patients with cancer that developed thrombosis. Clin Appl Thromb Hemost 2013;19:331-3. https://doi.org/10.1177/1076029611433644
  32. Goldstein DP, Irish JC. Head and neck squamous cell carcinoma in the young patient. Curr Opin Otolaryngol Head Neck Surg 2005;13:207-11. https://doi.org/10.1097/01.moo.0000170529.04759.4c
  33. Sarkaria JN, Harari PM. Oral tongue cancer in young adults less than 40 years of age: rationale for aggressive therapy. Head Neck 1994;16:107-11. https://doi.org/10.1002/hed.2880160202
  34. Veness MJ, Morgan GJ, Sathiyaseelan Y, Gebski V. Anterior tongue cancer: age is not a predictor of outcome and should not alter treatment. ANZ J Surg 2003;73:899-904. https://doi.org/10.1046/j.1445-2197.2003.02818.x
  35. Popovtzer A, Shpitzer T, Bahar G, Marshak G, Ulanovski D, Feinmesser R. Squamous cell carcinoma of the oral tongue in young patients. Laryngoscope 2004;114:915-7. https://doi.org/10.1097/00005537-200405000-00025
  36. Patel SC, Carpenter WR, Tyree S, Couch ME, Weissler M, Hackman T, et al. Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. J Clin Oncol 2011;29:1488-94. https://doi.org/10.1200/JCO.2010.31.7883
  37. Marocchio LS, Lima J, Sperandio FF, Correa L, de Sousa SO. Oral squamous cell carcinoma: an analysis of 1,564 cases showing advances in early detection. J Oral Sci 2010;52:267-73. https://doi.org/10.2334/josnusd.52.267
  38. Chow CW, Tabrizi SN, Tiedemann K, Waters KD. Squamous cell carcinomas in children and young adults: a new wave of a very rare tumor? J Pediatr Surg 2007;42:2035-9. https://doi.org/10.1016/j.jpedsurg.2007.08.025
  39. Zhang WB, Wang Y, Mao C, Guo CB, Yu GY, Peng X. Cervical metastasis of maxillary squamous cell carcinoma. Int J Oral Maxillofac Surg 2015;44:285-91. https://doi.org/10.1016/j.ijom.2014.10.020
  40. Zhang F, Chen Z, Wang P, Hu X, Gao Y, He J. Combination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patients. Tumour Biol 2016;37:9323-31. https://doi.org/10.1007/s13277-015-4774-3
  41. Khandavilli SD, Ceallaigh PO, Lloyd CJ, Whitaker R. Serum Creactive protein as a prognostic indicator in patients with oral squamous cell carcinoma. Oral Oncol 2009;45:912-4. https://doi.org/10.1016/j.oraloncology.2009.03.015
  42. Gockel I, Dirksen K, Messow CM, Junginger T. Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus. World J Gastroenterol 2006;12:3746-50. https://doi.org/10.3748/wjg.v12.i23.3746
  43. Park HC, Kim MY, Kim CH. C-reactive protein/albumin ratio as prognostic score in oral squamous cell carcinoma. J Korean Assoc Oral Maxillofac Surg 2016;42:243-50. https://doi.org/10.5125/jkaoms.2016.42.5.243

Cited by

  1. HDAC inhibitor apicidin suppresses murine oral squamous cell carcinoma cell growth in vitro and in vivo via inhibiting HDAC8 expression vol.16, pp.5, 2017, https://doi.org/10.3892/ol.2018.9468
  2. Increased Phosphatidylserine on Blood Cells in Oral Squamous Cell Carcinoma vol.98, pp.7, 2017, https://doi.org/10.1177/0022034519843106
  3. Analysis of Perioperative Platelet Indices and Their Prognostic Value in Head and Neck Cancer Patients Treated with Surgery and Postoperative Radiotherapy: A Retrospective Cohort Study vol.8, pp.11, 2019, https://doi.org/10.3390/jcm8111858
  4. The Platelecrit: The Role in Differential Diagnosis of Small Renal Masses vol.2, pp.56, 2017, https://doi.org/10.23950/1812-2892-jcmk-00752
  5. Prognostic role of platelet‐to‐lymphocyte ratio in oral cancer: A meta‐analysis vol.50, pp.3, 2017, https://doi.org/10.1111/jop.12832